Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial (Q58853389)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gilles Bourdoiseau

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Jean-Loup Lemesre

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Philippe Holzmuller

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Rachel Bras Gonçalves

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Christophe Hugnet

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Mireille Cavaleyra

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Gérard Papierok

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

0 references

publication date

15 March 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

4223-4234

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

The current status of zoonotic leishmaniases and approaches to disease control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Vaccine for prophylaxis and immunotherapy, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Visceral leishmaniasis in Teresina, State of Piauí, Brazil: preliminary observations on the detection and transmissibility of canine and sandfly infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Vaccines against leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Leishmaniasis: current status of vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Interferon-gamma and interleukin-4 in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.083

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.02.083

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395339%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58853389&oldid=1534271586"